Jerusalem based Oramed to dual list on TASE

Jerusalem based Oramed Pharmaceuticals Inc. (Nasdaq:ORMP), which develops orally administered drugs as a substitute for injections, has announced that the Israel Securities Authority has authorized the dual listing of its shares…

Continue Reading Jerusalem based Oramed to dual list on TASE